Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank95
5Y CAGR+110.7%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+110.7%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
41.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 63.04% |
| Q3 2025 | -137.08% |
| Q2 2025 | -9.83% |
| Q1 2025 | 23.64% |
| Q4 2024 | -41.16% |
| Q3 2024 | -13.17% |
| Q2 2024 | 68.04% |
| Q1 2024 | 8.34% |
| Q4 2023 | 17.70% |
| Q3 2023 | -6.69% |
| Q2 2023 | 39.07% |
| Q1 2023 | -74.61% |
| Q4 2022 | -2.33% |
| Q3 2022 | 21.62% |
| Q2 2022 | -51.46% |
| Q1 2022 | 28.66% |
| Q4 2021 | -55.42% |
| Q3 2021 | -89.02% |
| Q2 2021 | -9.32% |
| Q1 2021 | 14.02% |
| Q4 2020 | 1.52% |
| Q3 2020 | -4.69% |
| Q2 2020 | 1.10% |
| Q1 2020 | -34.57% |
| Q4 2019 | 0.00% |
| Q3 2019 | -0.96% |
| Q2 2019 | 0.00% |
| Q1 2019 | 40.20% |
| Q4 2018 | 0.00% |
| Q3 2018 | -379.20% |
| Q2 2018 | 0.00% |
| Q1 2018 | -165.85% |
| Q4 2017 | 0.00% |
| Q3 2017 | 68.55% |
| Q2 2017 | 0.00% |
| Q1 2017 | -2.09% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |